An education program to teach children to be healthy, a balanced diet and consistent exercise reduces the risk of developing diabetes, a disease that affects 592 million people in 2035, say scientists and managers from Novo Nordisk.
"We need to educate people about portion sizes, type of food and caloric density of the same task that involves different sectors, from the field of sales and advertising, to the restaurants," notes Lars Rebien Sorensen, President and CEO of the Danish company.
And, "Mexico sadly surpasses the United States as the most obese country in the world," says the manager in the context of a visit to the world's insulin factory, located Kolundborg.
According to statistics from the World Health Organization (WHO), in Mexico there are 10 million people with diabetes and the number is expected to increase to 16 million by 2030.
In addition, the atlas of diabetes says the number of people living with the disease rose to 382 million and 46 percent are undiagnosed. Every six seconds a person dies for this phenomenon, which in 2013 caused the death of 5.1 million and generated an expense of 548 billion dollars in treatments.
In the fight against diabetes, Lars Rebien Sorensen highlighted the work of the health authorities of the federal government and the city of Mexico, who "have much interest in doing something about it and have been welcomed our initiatives and proposals."
One of them, he said, is "Changing Diabetes Cities" program launched jointly with the city government last March, which seeks to add to all the cities around the world in the fight against diabetes.
"The idea is that cities start having numbers, a measure of diabetes risk population and from that see what the possible actions that can be implemented and shared between different cities on the efforts that each performs are" emphasized.
He said Mexico City, Shanghai, Houston and Copenhagen, which so far have been incorporated into this program, have little in common, but they share the fight against chronic diseases.
The executive producer of insulin described as "brave" the measures that the government of President Enrique Peña Nieto has implemented to regulate foods high in sugar or fat.
"The food industry is very important and powerful, however, be understood that each time should be more open to report on how developed their products," he said.
This industry needs to improve the labeling of products, so that the public has accurate information regarding the content of the food and thus can make good decisions about the use of the products, he said.
In this context, he announced that in the first week of September will be held in Mexico the global launch of a new insulin called Rizodeg.
Mads Krogsgaard Thomson, executive vice president and chief scientific officer of Novo Nordisk, said about this new drug, which combines a rapid-acting insulin with a slow-acting, 70 percent decrease in the likelihood of hypoglycemic events occur as occurs with other drugs.
He said the new insulin comes ready to use and their presentation is in liquid form, allowing better treatment and easy application.
He said that another interesting project that you work to Mexico is on a drug for the treatment of obesity, which is coming out soon and continue working to create insulin tablets, which may begin to develop in six or seven years.
He noted that in the struggle to find a cure for diabetes and produce new drugs, Novo Nordisk increased two thousand 500 million dollars, the amount allocated to research.
On a tour to world factory producing insulin, Jan Hoff and Susanne Stormer, production manager and vice president of Corporate Sustainability, respecticamente, explained the process for its production, from a genetically modified yeast.
0 comments:
Post a Comment